American Century Companies’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $8.32M | Sell |
161,025
-4,197
| -3% | -$214K | ﹤0.01% | 1543 |
|
|
2025
Q4 | $8.21M | Sell |
165,222
-344,146
| -68% | -$16.7M | ﹤0.01% | 1538 |
|
|
2025
Q3 | $24.3M | Sell |
509,368
-406,786
| -44% | -$16.4M | 0.01% | 1039 |
|
|
2025
Q2 | $28.9M | Sell |
916,154
-219,158
| -19% | -$7.02M | 0.02% | 916 |
|
|
2025
Q1 | $37.2M | Sell |
1,135,312
-5,393
| -0.5% | -$191K | 0.02% | 749 |
|
|
2024
Q4 | $41.2M | Buy |
1,140,705
+95,777
| +9% | +$3.37M | 0.02% | 716 |
|
|
2024
Q3 | $32.6M | Buy |
1,044,928
+543,270
| +108% | +$17M | 0.02% | 795 |
|
|
2024
Q2 | $13.4M | Buy |
501,658
+394,728
| +369% | +$11.4M | 0.01% | 1121 |
|
|
2024
Q1 | $3.65M | Buy |
106,930
+34,337
| +47% | +$1.02M | ﹤0.01% | 1599 |
|
|
2023
Q4 | $2.1M | Sell |
72,593
-3,940
| -5% | -$104K | ﹤0.01% | 1770 |
|
|
2023
Q3 | $2.11M | Buy |
76,533
+3,932
| +5% | +$120K | ﹤0.01% | 1676 |
|
|
2023
Q2 | $2.18M | Buy |
72,601
+13,331
| +22% | +$466K | ﹤0.01% | 1628 |
|
|
2023
Q1 | $2.15M | Sell |
59,270
-16,153
| -21% | -$621K | ﹤0.01% | 1583 |
|
|
2022
Q4 | $2.69M | Buy |
75,423
+35,927
| +91% | +$1.25M | ﹤0.01% | 1464 |
|
|
2022
Q3 | $1.34M | Buy |
39,496
+4,317
| +12% | +$140K | ﹤0.01% | 1586 |
|
|
2022
Q2 | $1.02M | Sell |
35,179
-49,801
| -59% | -$1.43M | ﹤0.01% | 1658 |
|
|
2022
Q1 | $2.75M | Sell |
84,980
-8,575
| -9% | -$263K | ﹤0.01% | 1307 |
|
|
2021
Q4 | $2.73M | Sell |
93,555
-41,973
| -31% | -$1.27M | ﹤0.01% | 1245 |
|
|
2021
Q3 | $3.62M | Buy |
135,528
+16,535
| +14% | +$444K | ﹤0.01% | 1110 |
|
|
2021
Q2 | $3.66M | Buy |
118,993
+29,032
| +32% | +$890K | ﹤0.01% | 1062 |
|
|
2021
Q1 | $2.35M | Sell |
89,961
-3,524
| -4% | -$98.6K | ﹤0.01% | 1113 |
|
|
2020
Q4 | $2.35M | Sell |
93,485
-4,505
| -5% | -$97K | ﹤0.01% | 1039 |
|
|
2020
Q3 | $2.04M | Buy |
97,990
+46,964
| +92% | +$1.07M | ﹤0.01% | 966 |
|
|
2020
Q2 | $1.21M | Buy |
51,026
+582
| +1% | +$12.9K | ﹤0.01% | 1033 |
|
|
2020
Q1 | $907K | Buy |
+50,444
| New | +$1.06M | ﹤0.01% | 1007 |
|
|
2019
Q3 | – | Sell |
-93,189
| Closed | -$3.08M | – | 1310 |
|
|
2019
Q2 | $3.08M | Buy |
93,189
+4,231
| +5% | +$145K | ﹤0.01% | 941 |
|
|
2019
Q1 | $3.12M | Buy |
88,958
+7,910
| +10% | +$294K | ﹤0.01% | 924 |
|
|
2018
Q4 | $2.69M | Buy |
81,048
+1,001
| +1% | +$43K | ﹤0.01% | 922 |
|
|
2018
Q3 | $4.03M | Buy |
80,047
+1,000
| +1% | +$49.4K | ﹤0.01% | 906 |
|
|
2018
Q2 | $4.73M | Hold |
79,047
| – | – | ﹤0.01% | 861 |
|
|
2018
Q1 | $3.62M | Buy |
+79,047
| New | +$3.3M | ﹤0.01% | 902 |
|
|
2017
Q4 | – | Sell |
-139,563
| Closed | -$5.58M | – | 1360 |
|
|
2017
Q3 | $5.58M | Sell |
139,563
-99,862
| -42% | -$4.32M | 0.01% | 824 |
|
|
2017
Q2 | $10.3M | Sell |
239,425
-46,239
| -16% | -$1.65M | 0.01% | 658 |
|
|
2017
Q1 | $8.94M | Buy |
285,664
+39,124
| +16% | +$1.05M | 0.01% | 705 |
|
|
2016
Q4 | $6.22M | Sell |
246,540
-28,017
| -10% | -$626K | 0.01% | 800 |
|
|
2016
Q3 | $6.79M | Sell |
274,557
-64,952
| -19% | -$1.47M | 0.01% | 768 |
|
|
2016
Q2 | $6.92M | Buy |
339,509
+189,337
| +126% | +$3.36M | 0.01% | 746 |
|
|
2016
Q1 | $2.29M | Buy |
+150,172
| New | +$1.96M | ﹤0.01% | 976 |
|
|
2015
Q4 | – | Sell |
-226,360
| Closed | -$3.18M | – | 1377 |
|
|
2015
Q3 | $3.18M | Buy |
226,360
+212,040
| +1,481% | +$3.94M | ﹤0.01% | 948 |
|
|
2015
Q2 | $243K | Buy |
+14,320
| New | +$204K | ﹤0.01% | 1304 |
|
Other funds holding SUPN
VPM
VCM
NAMI
AC
American Century Companies's SUPN Position: Q1 2026 in Review
American Century Companies reduced its Supernus Pharmaceuticals (SUPN) stake by 2.5% in Q1 2026, selling an estimated $214K and leaving 161,025 shares worth $8.32M. The position accounts for ﹤0.01% of the portfolio, ranked #1543.
American Century Companies first reported a position in SUPN in Q2 2015 and has held it in 40 quarters since. The position peaked at $41.2M in Q4 2024. 327 funds tracked by Wall St. Rank hold SUPN as of Q1 2026.
- American Century Companies held 161,025 shares of Supernus Pharmaceuticals worth $8.32M as of Q1 2026.
- American Century Companies sold 4,197 Supernus Pharmaceuticals shares in Q1 2026, an estimated $214K.
- Supernus Pharmaceuticals made up ﹤0.01% of American Century Companies's portfolio in Q1 2026, its #1543 holding.
- American Century Companies first reported a position in Supernus Pharmaceuticals in Q2 2015 and has held it in 40 quarters since.
- American Century Companies's Supernus Pharmaceuticals position peaked at $41.2M in Q4 2024.
- 327 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q1 2026.
Based on American Century Companies's 13F filing for Q1 2026, filed 15 May 2026.